In light of intermittent supply shortages of individual vaccines and evidence of rare but serious
adverse events after vaccination, heterologous regimens for COVID-19 vaccines have …

Background The use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine (CoronaVac) against SARS-CoV-2 is implemented worldwide. However, …

The coronavirus disease 2019 (COVID-19) pandemic has become a severe healthcare
problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 …

In June 2021, Thailand was hit by the delta variant of SARS-CoV-2 resulting in the biggest
wave of COVID-19. Due to the widespread delta variant, more than 600 healthcare workers …

The abundance of Aedes mosquito species enabled widespread transmission of mosquito-borne
chikungunya virus (CHIKV) and dengue virus (DENV) in Southeast Asia. Periodic …

Under selective pressure from the host immune system, antigenic epitopes of influenza
virus hemagglutinin (HA) have continually evolved to escape antibody recognition, termed …

Between 2018 and 2019, the incidence of chikungunya was approximately 15,000 cases
across 60 provinces in Thailand. Here, the clinical presentations in chikungunya, emergent …

The coronavirus 2019 omicron variant has surged rapidly and raises concerns about immune
evasion even in individuals with complete vaccination, because it harbors mutations. Here …

Coronavirus disease 2019 (COVID-19) booster vaccination is being comprehensively
evaluated globally due to waning immunity and the emergence of new severe acute respiratory …

Yearly increase in influenza activity is associated with cold and dry winter in the temperate
regions, while influenza patterns in tropical countries vary significantly by regional climates …